Insider Transactions Reported by 13 Insiders of Sofgen Pharma S.A.

Location: Luxembourg

Quick Takeaways

Sofgen Pharma S.A. has 13 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Sofgen Pharma S.A. executives and other stock owners filed with the SEC include:

Name	Relationship	Valuation	Report Date
Jose Minski	Director, 10%+ Owner	Mixed	29 Sep 2021
Ruben Minski	Chief Executive Officer, Director, 10%+ Owner	Mixed	29 Sep 2021
Deseja Trust	10%+ Owner	Mixed	29 Sep 2021
Angelini Melissa Andreia Silva	Interim CEO	Mixed	18 Mar 2026
Camacho Carlos Romero	Director	Mixed	18 Mar 2026
Claro Manuel Jose Vial	Director	Mixed	18 Mar 2026
Muniz Fernando Sebastian Moreira	Director, 10%+ Owner	Mixed	18 Mar 2026
Jaramillo Daniel Augusto Bernal	Director	Mixed	18 Mar 2026
Iragorri Carlos Garcia	Director	Mixed	18 Mar 2026
Alberto Eguiguren	Director	Mixed	18 Mar 2026
Luis Alberto Palacios	Chief Commercial Officer	Mixed	18 Mar 2026
Alexandre Weinstein Manieu	Director, 10%+ Owner	Mixed	18 Mar 2026
Nicolas Alexandre Weinstein	Director	Mixed	18 Mar 2026

Top shareholders of Sofgen Pharma S.A. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Flying Fish Ventures L.P.	13D/G	—	84%	2,077,549,443	$2,867,018,231	$0	09 Apr 2025	13D/G
Hoche Partners Pharma Holding S.A.	13D/G	—	84%	2,077,549,443	$2,867,018,231	$0	16 Apr 2025	13D/G
Saint Thomas Commercial S.A.	13D/G	—	84%	2,077,549,443	$2,867,018,231	$0	09 Apr 2025	13D/G
Becaril S.A.	13D/G	—	53%	1,304,518,234	$1,800,235,163	$0	09 Apr 2025	13D/G
Chemo Project, S.A.	13D/G	—	53%	1,304,518,234	$1,800,235,163	$0	09 Apr 2025	13D/G
Alexandre Weinstein Manieu	3/4/5	Director, 10%+ Owner	— class O/S missing	626,495,816	—	—	18 Mar 2026	3/4/5
Muniz Fernando Sebastian Moreira	3/4/5	Director, 10%+ Owner	— class O/S missing	305,309,149	—	—	18 Mar 2026	3/4/5
Ruben Minski	3/4/5	Chief Executive Officer, Director, 10%+ Owner	— class O/S missing	31,338,454	—	—	29 Sep 2021	3/4/5
Deseja Trust	3/4/5	10%+ Owner	— class O/S missing	17,960,146	—	—	29 Sep 2021	3/4/5
Jose Minski	3/4/5	Director, 10%+ Owner	— class O/S missing	17,960,146	—	—	29 Sep 2021	3/4/5

Recent Insider Transactions by Companies or Individuals for Sofgen Pharma S.A.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Muniz Fernando Sebastian Moreira	PROCF	Ordinary Shares					0	305,309,149	18 Mar 2026	By Becaril S.A.
Alexandre Weinstein Manieu		Ordinary Shares					0	626,495,816	18 Mar 2026	By Hoche Partners Pharma Holdings LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.